XML 60 R28.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Compensation Plans
12 Months Ended
Dec. 31, 2012
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Compensation Plans
Stock Compensation Plans
Our 2002 Performance Plan and 2005 Performance Plan (collectively the “Plans”) permitted grants of performance share units, stock options, stock appreciation rights (“SARs”), and restricted stock to employees. The Plans expired on April 15, 2005 and April 26, 2008, respectively, except for grants then outstanding. Our 2008 Performance Plan, which was adopted on April 8, 2008 and is due to expire on April 8, 2018, permits the grant of performance share units, stock options, SARs, restricted stock, restricted stock units, other stock-based grants and awards and cash-based grants and awards to employees and directors. A total of 8,000,000 shares of our common stock may be issued in respect of grants made under the 2008 Performance Plan. Any shares of common stock that are subject to awards of stock options or SARs will be counted as one share for each share granted for purposes of the aggregate share limit and any shares of common stock that are subject to any other awards will be counted as 1.61 shares for each share granted for purposes of the aggregate share limit. In addition, shares of common stock that are subject to awards issued under the 2008 Performance Plan or certain prior equity compensation plans that expire according to their terms or are forfeited, terminated, canceled or surrendered or are settled, or can be paid, only in cash will be available for issuance pursuant to a new grant or award under the 2008 Performance Plan. Shares issued under our stock-based compensation plans are usually issued from shares of our common stock held in treasury.
Stock Options
Grants of stock options and SARs (collectively referred to as “options”) under the Plans and the 2008 Performance Plan generally have a graded vesting period of four years whereby one-fourth of the awards vest on each of the first four anniversaries of the grant date, an exercise price equal to the fair market value of one share of our common stock on the date of grant (calculated as the average of the high and low price on that date or, with respect to the 2008 Performance Plan, the closing market price on that date) and a contractual term of ten years. The exercise of tandem SARs cancels an equivalent number of stock options and conversely, the exercise of stock options cancels an equivalent number of tandem SARs. Option grants are cancelled on, or 90 days following, termination of employment unless termination is due to retirement, death or disability under certain circumstances, in which case, all outstanding options vest fully and remain outstanding for a term set forth in the related grant agreement.
Under the Plans, the exercise of certain stock options through a share swap, whereby the employee exercising the stock options tenders shares of our common stock then owned by such employee towards the exercise price plus taxes, if any, due from such employee, results in an immediate grant of new options (hereinafter referred to as “reload” options) equal to the number of shares so tendered plus any shares tendered to satisfy the employee’s income tax obligations on the transaction. Each such grant of reload options vests on the first anniversary of its respective grant date, has an exercise price equal to the fair market value of one share of our common stock on the date of grant (calculated as the average of the high and low price on that date) and a contractual term equal to the remaining contractual term of the original option. The subsequent exercise of such reload options through a share swap does not result in the grant of any additional reload options. The 2008 Performance Plan does not permit the grant of reload options.
The following table summarizes the activity related to options during 2012:

 
Options
 
Weighted Average
Exercise Price
 
Weighted Average
Remaining
Contractual Term
(Years)
 
Aggregate Intrinsic
Value (In millions)
Outstanding at January 1
12,787,824

 
$
14.84

 
 
 
 

Options granted
2,004,429

 
12.79

 
 
 
 

Options exercised
(513,910
)
 
7.98

 
 
 
$
2

Options expired
(140,502
)
 
8.89

 
 
 
 

Options cancelled
(608,979
)
 
17.34

 
 
 
 

Outstanding at December 31
13,528,862

 
14.75

 
5.5
 
26

Vested and expected to vest at December 31
13,049,005

 
14.84

 
5.3
 
24

Exercisable at December 31
9,166,525

 
15.92

 
4.1
 
19

Available for grant at December 31
6,510,610

 
 

 
 
 
 



In addition, the aggregate intrinsic value of options exercised in 2011 and 2010 was $10 million and $1 million, respectively.
Significant option groups outstanding at December 31, 2012 and related weighted average exercise price and remaining contractual term information follows:

Grant Date
 
Options Outstanding
 
Options Exercisable
 
Exercise Price
 
Remaining Contractual Term(Years)
2/27/2012
 
1,734,582

 
4,156

 
$
12.94

 
9.2

2/22/2011
 
1,311,165

 
343,417

 
13.91

 
8.2

2/23/2010
 
1,250,773

 
665,443

 
12.74

 
7.2

2/26/2009
 
1,631,988

 
1,230,591

 
4.81

 
6.2

2/21/2008
 
1,109,994

 
1,109,994

 
26.74

 
5.2

2/27/2007
 
1,239,522

 
1,239,522

 
24.71

 
4.2

12/6/2005
 
825,642

 
825,642

 
17.15

 
2.9

12/9/2004
 
1,465,881

 
1,465,881

 
12.54

 
1.9

12/2/2003
 
682,576

 
682,576

 
6.81

 
0.9

All other
 
2,276,739

 
1,599,303

 
(1
)
 
(1
)
 
 
13,528,862

 
9,166,525

 
 

 
 

_______________________________________
(1)
Options in the “All other” category had exercise prices ranging from $5.52 to $36.25. The weighted average exercise price for options outstanding and exercisable in that category was $16.52 and $18.27, respectively, while the remaining weighted average contractual term was 5.0 and 3.5 years, respectively.
Weighted average grant date fair values of stock options and the assumptions used in estimating those fair values are as follows:

 
2012
 
2011
 
2010
Weighted average grant date fair value
$
6.33

 
$
6.94

 
$
6.45

Black-Scholes model assumptions (1):
 

 
 

 
 

Expected term (years)
6.25

 
6.25

 
6.25

Interest rate
1.09
%
 
2.28
%
 
2.58
%
Volatility
50.8
%
 
49.5
%
 
50.5
%
Dividend yield

 

 

_______________________________________
(1)
We review the assumptions used in our Black-Scholes model in conjunction with estimating the grant date fair value of the annual grants of stock-based awards by our Board of Directors.
Performance Share Units
Performance share units granted under the 2008 Performance Plan are earned over a three-year period beginning January 1 of the year of grant. Total units earned for grants made in 2012, may vary between 0% and 200% of the units granted based on the attainment of performance targets during the related three-year period and continued service. Total units earned for grants made in 2011 and 2010, may vary between 0% and 150% of the units granted based on the attainment of performance targets during the related three-year period and continued service. The performance targets are established by the Board of Directors. All of the units earned will be settled through the issuance of an equivalent number of shares of our common stock and are equity classified.
Eligible employees may elect to defer receiving the payout of all or a portion of their units earned until termination of employment. For grants made in 2010 and later under the 2008 Performance Plan, each deferred unit equates to one share of our common stock and is payable 100% in shares of our common stock at the expiration of the deferral period.
The following table summarizes the activity related to performance share units during 2012:

 
Units
Weighted Average Grant Date Fair Value
Unvested at January 1
295,460

$
14.13

Units granted
174,877

13.57

Units vested
(132,845
)
12.55

Units forfeited
(18,563
)
14.14

Unvested at December 31
318,929

14.48


We measure the fair value of grants of performance share units based primarily on the closing market price of a share of our common stock on the date of the grant, modified as appropriate to take into account the features of such grants.
Other Information
Stock-based compensation expense, cash payments made to settle SARs and performance share units, and cash received from the exercise of stock options follows:

(In millions)
2012
 
2011
 
2010
Stock-based compensation expense recognized
$
15

 
$
18

 
$
26

Tax impact

 

 

After-tax stock-based compensation expense
$
15

 
$
18

 
$
26

Cash payments to settle SARs and performance share units
$

 
$

 
$

Cash received from stock option exercises
4

 
8

 
1


As of December 31, 2012, unearned compensation cost related to the unvested portion of all stock-based awards was approximately $25 million and is expected to be recognized over the remaining vesting period of the respective grants, through December 31, 2016.